Integrated Diagnostics (LON:IDHC) Trading Up 14.3% – Time to Buy?

Integrated Diagnostics Holdings plc (LON:IDHC)’s stock price shot up 14.3% on Saturday . The company traded as high as GBX 0.40 ($0.01) and last traded at GBX 0.40 ($0.01). 707,083 shares were traded during mid-day trading, an increase of 283% from the average session volume of 184,474 shares. The stock had previously closed at GBX 0.35 ($0.00).

Integrated Diagnostics Stock Up 14.3 %

The company’s 50 day simple moving average is GBX 0.36 and its 200-day simple moving average is GBX 0.40. The company has a current ratio of 1.59, a quick ratio of 0.75 and a debt-to-equity ratio of 45.72. The firm has a market cap of £11.77 billion, a P/E ratio of 14.87, a PEG ratio of 7.65 and a beta of 0.59.

About Integrated Diagnostics

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia).